US Intravenous (IV) hydration therapy Market Size study, by Service (Immune Boosters, Energy Boosters, Skin Care, Migraine, Other), by Component (Medicated, Non-medicated), by End User (Hospitals & Clinics, Wellness centres and spas, Home Healthcare, Others) Forecasts 2022-2032
US Intravenous (IV) hydration therapy Market is valued at approximately USD 854.47 million in 2023 and is anticipated to grow with a healthy growth rate of more than 8.40% over the forecast period 2024-2032. The US Intravenous (IV) Hydration Therapy Market is centered around providing fluids directly into the bloodstream to address dehydration and provide necessary nutrients. Numerous key patterns have contributed to substantial market expansion. The growing occurrence of long-term illnesses like diabetes and cancer has raised the need for IV hydration therapy, particularly in hospitals. The rise in demand for wellness and preventive healthcare has resulted in a growth in the number of outpatient clinics and mobile IV therapy services, boosting market expansion. Moreover, the increasing number of older people around the world has led to a surge in the need for IV hydration treatment for senior patients who may struggle to drink fluids by mouth. The market growth for IV therapy is continuing to increase with the help of technology like smart pumps and integrated monitoring systems, which improve safety and efficiency. These patterns are attracting focus and funding in the US Intravenous (IV) Hydration Therapy Market.
The US Intravenous (IV) Hydration Therapy Market is driven by diverse factors that is the rising number of chronic illnesses, which is resulting in a greater need for IV therapy in medical environments. This trend shows an increasing demand for effective and specific hydration options, particularly among patients with complicated medical issues. However, in addition to these factors, the market encounters some limitations. An important limitation is the possible dangers linked with IV treatment, such as infection, excessive fluid, and vein inflammation. Stringent protocols and skilled healthcare professionals are required to guarantee safe and effective treatment due to these risks. Healthcare providers and industry stakeholders face a critical challenge in balancing the advantages of IV Hydration Therapy with its associated risks, which impact market dynamics and adoption rates.
Major market player included in this report are:
Baxter International Inc.
B. Braun Medical Inc
ICU Medical, Inc.
Smiths Medical, Inc.
Core IV Therapy, LLC
NextGen Healthcare Information Systems, LLC
Drip Hydration
NutriDrip
REVIV
VitaSquad
The detailed segments and sub-segment of the market are explained below:
By Service
Immune Boosters
Energy Boosters
Skin Care
Migraine
Other
By Component
Medicated
Non-medicated
By End User
Hospitals & Clinics
Wellness centres and spas
Home Healthcare
Others
Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.
The US Intravenous (IV) Hydration Therapy Market is driven by diverse factors that is the rising number of chronic illnesses, which is resulting in a greater need for IV therapy in medical environments. This trend shows an increasing demand for effective and specific hydration options, particularly among patients with complicated medical issues. However, in addition to these factors, the market encounters some limitations. An important limitation is the possible dangers linked with IV treatment, such as infection, excessive fluid, and vein inflammation. Stringent protocols and skilled healthcare professionals are required to guarantee safe and effective treatment due to these risks. Healthcare providers and industry stakeholders face a critical challenge in balancing the advantages of IV Hydration Therapy with its associated risks, which impact market dynamics and adoption rates.
Major market player included in this report are:
Baxter International Inc.
B. Braun Medical Inc
ICU Medical, Inc.
Smiths Medical, Inc.
Core IV Therapy, LLC
NextGen Healthcare Information Systems, LLC
Drip Hydration
NutriDrip
REVIV
VitaSquad
The detailed segments and sub-segment of the market are explained below:
By Service
Immune Boosters
Energy Boosters
Skin Care
Migraine
Other
By Component
Medicated
Non-medicated
By End User
Hospitals & Clinics
Wellness centres and spas
Home Healthcare
Others
Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.
CHAPTER 1. US INTRAVENOUS (IV) HYDRATION THERAPY MARKET DEFINITION AND RESEARCH ASSUMPTIONS
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates
CHAPTER 2. EXECUTIVE SUMMARY
2.1. US Intravenous (IV) Hydration Therapy Market Size & Forecast (2022- 2032)
2.2. Segmental Summary
2.2.1. By Service
2.2.2. By Component
2.2.3. By End User
2.3. Key Trends
2.4. Recession Impact
2.5. Analyst Recommendation & Conclusion
CHAPTER 3. US INTRAVENOUS (IV) HYDRATION THERAPY MARKET DYNAMICS
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
CHAPTER 4. US INTRAVENOUS (IV) HYDRATION THERAPY MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. US INTRAVENOUS (IV) HYDRATION THERAPY MARKET SIZE & FORECASTS BY SERVICE 2022-2032
5.1. Immune Boosters
5.2. Energy Boosters
5.3. Skin Care
5.4. Migraine
5.5. Other
CHAPTER 6. US INTRAVENOUS (IV) HYDRATION THERAPY MARKET SIZE & FORECASTS BY COMPONENT 2022-2032
6.1. Medicated
6.2. Non-medicated
CHAPTER 7. US INTRAVENOUS (IV) HYDRATION THERAPY MARKET SIZE & FORECASTS BY END USER 2022-2032
7.1. Hospitals & Clinics
7.2. Wellness centres and spas
7.3. Home Healthcare
7.4. Others
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Key Company SWOT Analysis
8.1.1. Baxter International Inc.
8.1.2. B. Braun Medical Inc
8.1.3. ICU Medical, Inc.
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Baxter International Inc.
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. B. Braun Medical Inc
8.3.3. ICU Medical, Inc.
8.3.4. Smiths Medical, Inc.
8.3.5. Core IV Therapy, LLC
8.3.6. NextGen Healthcare Information Systems, LLC
8.3.7. Drip Hydration
8.3.8. NutriDrip
8.3.9. REVIV
8.3.10. VitaSquad
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates
CHAPTER 2. EXECUTIVE SUMMARY
2.1. US Intravenous (IV) Hydration Therapy Market Size & Forecast (2022- 2032)
2.2. Segmental Summary
2.2.1. By Service
2.2.2. By Component
2.2.3. By End User
2.3. Key Trends
2.4. Recession Impact
2.5. Analyst Recommendation & Conclusion
CHAPTER 3. US INTRAVENOUS (IV) HYDRATION THERAPY MARKET DYNAMICS
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
CHAPTER 4. US INTRAVENOUS (IV) HYDRATION THERAPY MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. US INTRAVENOUS (IV) HYDRATION THERAPY MARKET SIZE & FORECASTS BY SERVICE 2022-2032
5.1. Immune Boosters
5.2. Energy Boosters
5.3. Skin Care
5.4. Migraine
5.5. Other
CHAPTER 6. US INTRAVENOUS (IV) HYDRATION THERAPY MARKET SIZE & FORECASTS BY COMPONENT 2022-2032
6.1. Medicated
6.2. Non-medicated
CHAPTER 7. US INTRAVENOUS (IV) HYDRATION THERAPY MARKET SIZE & FORECASTS BY END USER 2022-2032
7.1. Hospitals & Clinics
7.2. Wellness centres and spas
7.3. Home Healthcare
7.4. Others
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Key Company SWOT Analysis
8.1.1. Baxter International Inc.
8.1.2. B. Braun Medical Inc
8.1.3. ICU Medical, Inc.
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Baxter International Inc.
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. B. Braun Medical Inc
8.3.3. ICU Medical, Inc.
8.3.4. Smiths Medical, Inc.
8.3.5. Core IV Therapy, LLC
8.3.6. NextGen Healthcare Information Systems, LLC
8.3.7. Drip Hydration
8.3.8. NutriDrip
8.3.9. REVIV
8.3.10. VitaSquad
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
LIST OF TABLES
TABLE 1. US Intravenous (IV) Hydration Therapy market, report scope
TABLE 2. US Intravenous (IV) Hydration Therapy market estimates & forecasts by Service 2022-2032 (USD Million)
TABLE 3. US Intravenous (IV) Hydration Therapy market estimates & forecasts by Component 2022-2032 (USD Million)
TABLE 4. US Intravenous (IV) Hydration Therapy market estimates & forecasts by End User 2022-2032 (USD Million)
TABLE 5. US Intravenous (IV) Hydration Therapy market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 6. US Intravenous (IV) Hydration Therapy market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 7. US Intravenous (IV) Hydration Therapy market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 8. US Intravenous (IV) Hydration Therapy market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 9. US Intravenous (IV) Hydration Therapy market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 10. U.S. Intravenous (IV) Hydration Therapy market estimates & forecasts, 2022-2032 (USD Million)
TABLE 11. U.S. Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 12. U.S. Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 13. List of secondary sources, used in the study of US Intravenous (IV) Hydration Therapy Market.
TABLE 14. List of primary sources, used in the study of US Intravenous (IV) Hydration Therapy Market.
TABLE 15. Years considered for the study.
TABLE 16. Exchange rates considered.
TABLE 1. US Intravenous (IV) Hydration Therapy market, report scope
TABLE 2. US Intravenous (IV) Hydration Therapy market estimates & forecasts by Service 2022-2032 (USD Million)
TABLE 3. US Intravenous (IV) Hydration Therapy market estimates & forecasts by Component 2022-2032 (USD Million)
TABLE 4. US Intravenous (IV) Hydration Therapy market estimates & forecasts by End User 2022-2032 (USD Million)
TABLE 5. US Intravenous (IV) Hydration Therapy market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 6. US Intravenous (IV) Hydration Therapy market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 7. US Intravenous (IV) Hydration Therapy market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 8. US Intravenous (IV) Hydration Therapy market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 9. US Intravenous (IV) Hydration Therapy market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 10. U.S. Intravenous (IV) Hydration Therapy market estimates & forecasts, 2022-2032 (USD Million)
TABLE 11. U.S. Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 12. U.S. Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 13. List of secondary sources, used in the study of US Intravenous (IV) Hydration Therapy Market.
TABLE 14. List of primary sources, used in the study of US Intravenous (IV) Hydration Therapy Market.
TABLE 15. Years considered for the study.
TABLE 16. Exchange rates considered.
LIST OF FIGURES
FIG 1. US Intravenous (IV) Hydration Therapy market, research methodology
FIG 2. US Intravenous (IV) Hydration Therapy market, market estimation techniques
FIG 3. US market size estimates & forecast methods.
FIG 4. US Intravenous (IV) Hydration Therapy market, key trends 2023
FIG 5. US Intravenous (IV) Hydration Therapy market, growth prospects 2022-2032
FIG 6. US Intravenous (IV) Hydration Therapy market, porters 5 force model
FIG 7. US Intravenous (IV) Hydration Therapy market, pestel analysis
FIG 8. US Intravenous (IV) Hydration Therapy market, value chain analysis
FIG 9. US Intravenous (IV) Hydration Therapy market by segment, 2022 & 2032 (USD Million)
FIG 10. US Intravenous (IV) Hydration Therapy market by segment, 2022 & 2032 (USD Million)
FIG 11. US Intravenous (IV) Hydration Therapy market by segment, 2022 & 2032 (USD Million)
FIG 12. US Intravenous (IV) Hydration Therapy market by segment, 2022 & 2032 (USD Million)
FIG 13. US Intravenous (IV) Hydration Therapy market by segment, 2022 & 2032 (USD Million)
FIG 14. US Intravenous (IV) Hydration Therapy market, company market share analysis (2023)
FIG 1. US Intravenous (IV) Hydration Therapy market, research methodology
FIG 2. US Intravenous (IV) Hydration Therapy market, market estimation techniques
FIG 3. US market size estimates & forecast methods.
FIG 4. US Intravenous (IV) Hydration Therapy market, key trends 2023
FIG 5. US Intravenous (IV) Hydration Therapy market, growth prospects 2022-2032
FIG 6. US Intravenous (IV) Hydration Therapy market, porters 5 force model
FIG 7. US Intravenous (IV) Hydration Therapy market, pestel analysis
FIG 8. US Intravenous (IV) Hydration Therapy market, value chain analysis
FIG 9. US Intravenous (IV) Hydration Therapy market by segment, 2022 & 2032 (USD Million)
FIG 10. US Intravenous (IV) Hydration Therapy market by segment, 2022 & 2032 (USD Million)
FIG 11. US Intravenous (IV) Hydration Therapy market by segment, 2022 & 2032 (USD Million)
FIG 12. US Intravenous (IV) Hydration Therapy market by segment, 2022 & 2032 (USD Million)
FIG 13. US Intravenous (IV) Hydration Therapy market by segment, 2022 & 2032 (USD Million)
FIG 14. US Intravenous (IV) Hydration Therapy market, company market share analysis (2023)
